Initial depletion of regulatory T cells: The missing solution to preserve the immune functions of T lymphocytes designed for cell therapy

Blood

Volumn 107, Issue 1, 2006, Pages 381-388

  Mesel Lemoine, Mariana ^b   Cherai, Mustapha ^b   Le Gouvello, Sabine ^b   Guillot, Maude ^b   Leclercq, Virginie ^b   Klatzmann, David ^b   Thomas Vaslin, Véronique ^b   Lemoine, François M ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; INTERLEUKIN 2; MESSENGER RNA; MONOCLONAL ANTIBODY CD28; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIVISION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; GENE THERAPY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IRRADIATION; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN GRAFT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 30144432417     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-07-2658     Document Type: Article

References (46)

1. Unutmaz D, KewalRamani VN, Marmon S, Littman DR. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med. 1999;189:1735-1746.
2. Movassagh M, Boyer O, Burland MC, Leclercq V, Klatzmann D, Lemoine FM. Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection. Hum Gene Ther. 2000;11:1189-1200.
3. Hagani AB, Riviere I, Tan C, Krause A, Sadelain M. Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection. J Gene Med. 1999;1:341-351.
4. Contassot E, Murphy W, Angonin R, et al. In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes. Transplantation. 1998;65:1365-1370.
5. Sauce D, Tonnelier N, Duperrier A, et al. Influence of ex vivo expansion and retrovirus-mediated gene transfer on primary T lymphocyte phenotype and functions. J Hematother Stem Cell Res. 2002;11:929-940.
6. Sauce D, Bodinier M, Garin M, et al. Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood. 2002;99:1165-1173.
7. Chai JG, Lechler RI. Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4+ T cells in vitro. Int Immunol. 1997;9:935-944.
8. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188:287-296.
9. + regulatory T cells from human peripheral blood. J Immunol. 2001;166:7282-7289.
10. Annacker O, Burlen-Defranoux O, Pimenta-Araujo R, Cumano A, Bandeira A. Regulatory CD4 T cells control the size of the peripheral activated/ memory CD4 T cell compartment. J Immunol. 2000;164:3573-3580.
11. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol. 2001;166:3008-3018.
12. + T cell numbers. J Immunol. 2002;169:4850-4860.
13. + T cell responses. J Exp Med. 2002;196:1585-1592.
14. + T cells. Proc Natl Acad Sci U S A. 2002;99:8832-8837.
15. + regulatory T cells. Nat Med. 2004;10:29-30.
16. + regulatory T cells in Leishmania infection. Expert Opin Biol Ther. 2003;3:875-885.
17. + regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol. 2004;34:336-344.
18. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942-949.
19. Kinter AL, Hennessey M, Bell A, et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med. 2004;200:331-343.
20. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood. 2004;104:3249-3256.
21. Lemoine FM, Mesel-Lemoine M, Cherai M, et al. Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line. J Gene Med. 2004;6:374-386.
22. Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol. 2001;166:973-981.
23. Dupuy FP, Mouly E, Mesel-Lemoine M, et al. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters. J Gene Med. 2005;7:1158-1171.
24. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res. 1996;6:995-1001.
25. Ferrand C, Robinet E, Contassot E, et al. Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire. Hum Gene Ther. 2000;11:1151-1164.
26. Qasim W, King D, Buddle J, et al. The impact of retroviral suicide gene transduction procedures on T cells. Br J Haematol. 2003;123:712-719.
27. Wolf H, Muller Y, Salmen S, Wilmanns W, Jung G. Induction of anergy in resting human T lymphocytes by immobilized anti-CD3 antibodies. Eur J Immunol. 1994;24:1410-1417.
28. Fraser JD, Newton ME, Weiss A. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J Exp Med. 1992;175:1131-1134.
29. Muller Y, Wolf H, Wierenga E, Jung G. Induction of abortive and productive proliferation in resting human T lymphocytes via CD3 and CD28. Immunology. 1999;97:280-286.
30. + T-cell responses against herpes simplex virus type 1. J Virol. 2004;78:13082-13089.
31. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22:329-341.
32. Roncador G, Brown PJ, Maestre L, et al. Analysis of FOXP3 protein expression in human CD4(+) CD25(+) regulatory T cells at the single-cell level. Eur J Immunol. 2005;35:1681-1691.
33. - cells. Proc Natl Acad Sci U S A. 2005;102:4103-4108.
34. - T cells. J Clin Invest. 2003;112:1437-1443.
35. Waldmann TA, Dubois S, Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity. 2001;14:105-110.
36. Strengell M, Matikainen S, Siren J, et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol. 2003;170:5464-5469.
37. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol. 2003;3:269-279.
38. Wells AD. Cell-cycle regulation of T-cell responses-novel approaches to the control of alloimmunity. Immunol Rev. 2003;196:25-36.
39. Kalamasz D, Long SA, Taniguchi R, Buckner JH, Berenson RJ, Bonyhadi M. Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and anti-CD28 antibodies. J Immunother. 2004;27:405-418.
40. Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood. 2004;104:895-903.
41. Cohen JL, Boyer O, Klatzmann D. Would suicide gene therapy solve the T-cell dilemma of allogeneic bone marrow transplantation? Immunol Today. 1999;20:172-176.
42. Bonini C, Ferrari G, Verzeletti S, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 1997;276:1719-1724.
43. Cohen JL, Saron MF, Boyer O, et al. Preservation of graft-versus- infection effects after suicide gene therapy for prevention of graft-versus-host disease. Hum Gene Ther. 2000;11:2473-2481.
44. + T cells. Adv Immunol. 2003;81:331-371.
45. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003;9:1144-1150.
46. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest. 2003;112:1688-1696.